about
Comparison of bag-valve-mask hand-sealing techniques in a simulated model.Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock.Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease.A multicenter mortality prediction model for patients receiving prolonged mechanical ventilation.Mitogen-activated protein kinase phosphatase-1 modulates regional effects of injurious mechanical ventilation in rodent lungs.Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease?Cell death, remodeling, and repair in chronic obstructive pulmonary disease?Angiogenesis in chronic lung diseasePerspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis.Beta-catenin in the fibroproliferative response to acute lung injuryAcute kidney injury in the intensive care unit: an update and primer for the intensivist.Corticosteroid use in the intensive care unit: a survey of intensivists.Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients.Chemokine-mediated angiogenesis: an essential link in the evolution of airway fibrosis?Statistical analysis plan of PROWESS SHOCK study.Diabetes mellitus does not adversely affect outcomes from a critical illness.Laboratory predictors of relative adrenal insufficiency in septic shock.Observational study of head of bed elevation adherence using a continuous monitoring system in a medical intensive care unit.EphA2 Modulation Associates with Protective Effect of Prone Position in Ventilator-induced Lung Injury.Drotrecogin alfa (activated) in adults with septic shock.CD4+ T cell and eosinophil adhesion is mediated by specific ICAM-3 ligation and results in eosinophil activationActive screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospitalAcute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injuryManaging a rare condition presenting with intractable hypoxemic respiratory failureRegulatory role of gammadelta T cells in the recruitment of CD4+ and CD8+ T cells to lung and subsequent pulmonary fibrosisLipid A fraction of LPS induces a discrete MAPK activation in acute lung injuryProphylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)Possible explanations for the results of CRASHInterleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomyJunior doctors' working hours: a view from across the pond (3)Unblinding plan of PROWESS-SHOCK trialRisk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumoniaApproaches to achieving universal health care in the United States: where should the American thoracic society stand?Update in Critical Care and Acute Respiratory Distress Syndrome 2018Variability in usual care fluid resuscitation and risk-adjusted outcomes for mechanically ventilated patients in shockAntibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM
P50
Q27333663-0618B30A-715B-4A52-B6D0-94729267D620Q28284276-50616175-E521-4982-996B-8D692E060784Q34370297-5D554DE7-2A71-4BF8-840B-5D454AE27CA6Q34538815-0B131E1C-F4FE-4A69-A00C-4D240F5172E7Q36091305-6687B580-2863-4297-99BF-9B9F7C52EDD4Q36105866-BA472689-3233-432D-B9EE-B0962F9D1052Q36634721-6FF62611-D99F-40BF-9460-A984E8A0A2C7Q36634744-263E8BBF-46E3-4242-98DA-D73DC2DE81F3Q36758867-CF6B6ABF-6BCF-4319-AE0D-344CB7F9CB74Q36769644-3EEFA49A-E847-4C29-82E2-8896DCC8BC59Q37045970-67A8A448-892F-4002-A79C-5BA6F2B4BC41Q37101052-2F458CA0-3326-4B5F-B40C-6AF62D289AD8Q37614835-86790C61-8F09-4F47-8A5E-D98DCAE85DF4Q39432057-836DAA86-A0F6-40A7-9211-7AF3C61E4F8DQ39780554-90FDD806-3930-4F44-978B-C0BC4569A479Q41858070-FF538844-459C-4B5B-AD61-CD9FF12A8E29Q42679358-3B09113B-2026-4191-A659-EC6A97370B12Q44067040-3BF2E80E-19F6-4172-B41D-50EC22A6617CQ44584431-2CEF129C-4A5E-47A4-ACD5-7ABBC7A60098Q44616189-7C8D5AAF-766D-40E1-BD99-6A80BE843D06Q47319276-883BCBA0-2ABA-4094-B87A-7FB989900A16Q55056165-BEB0C19E-DC39-48A3-874C-62A6E0867E74Q73520616-E601F932-1F27-4497-B49E-B8FED8160970Q79151946-A6E273A1-E700-487F-89EF-27C5BD112546Q79431461-8D6E526C-EC7F-4E65-A546-F986FD28756FQ79546359-77911CD6-8A46-48F1-B9C7-FC0627BD04B1Q80284057-E8D0B5D5-E387-4A40-8804-8C248C3226DEQ80316641-1F1F4498-8B9E-4AD4-B303-9887C02D32CEQ80447715-9FC72546-54C8-44EB-A2DA-73ECAD57D17FQ81277586-959AE1D4-70D9-436B-BFD1-C8086B47AB25Q81569172-414661C3-F0E6-4F19-A97E-30B68044EF79Q81634507-BA3477E0-5005-4A59-81E6-4D3BDB1B6953Q84405548-F346168C-ED07-4211-80E8-A16BF4B911CEQ84774274-0BA425C0-326A-4835-A724-ADD65B936A70Q84865922-DB3E279F-7568-40D3-9EBC-FB7813111CC9Q92929754-5240D3C4-5B3C-4AC2-9C2D-E866ECF5A215Q93010137-629B298E-F14D-4FC1-AB21-B152BB790966Q94478450-C687E235-F14E-4941-B057-26F0C2D89410
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ivor S Douglas
@ast
Ivor S Douglas
@en
Ivor S Douglas
@es
Ivor S Douglas
@nl
Ivor S Douglas
@sl
type
label
Ivor S Douglas
@ast
Ivor S Douglas
@en
Ivor S Douglas
@es
Ivor S Douglas
@nl
Ivor S Douglas
@sl
prefLabel
Ivor S Douglas
@ast
Ivor S Douglas
@en
Ivor S Douglas
@es
Ivor S Douglas
@nl
Ivor S Douglas
@sl
P106
P31
P496
0000-0002-4541-1431